cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Fusion Pharmaceuticals Inc
7 own
24 watching
Current Price
$2.37
$-0.03
(-1.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
223.13M
52-Week High
52-Week High
5.63000
52-Week Low
52-Week Low
1.98000
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization223.13M
icon52-Week High5.63000
icon52-Week Low1.98000
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Fusion Pharmaceuticals Inc do?
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Its lead product candidate is FPI-1434 that is in Phase 1 clinical trials as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company is also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it is progressing its earlier-stage product candidate, FPI-1966 into clinical development for the treatment of head and neck, and bladder cancers expressing fibroblast growth factor receptor. The company has a strategic collaboration agreement with AstraZeneca UK Limited to jointly discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
Read More
How much money does Fusion Pharmaceuticals Inc make?
News & Events about Fusion Pharmaceuticals Inc.
TipRanks Financial Blog
3 months ago
JonesTrading analyst Justin Walsh maintained a Buy rating on Fusion Pharmaceuticals (FUSN Research Report) today and set a price target of $12.00... JonesTrading analyst Justin Walsh maintained a Buy rating on Fusion Pharmaceuticals (FUSN Resear...
PR Newswire
3 months ago
Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R PR Newswire HAMILTON, ON and BOSTON, June 26...
CNW Group - News Releases
3 months ago
Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R Canada NewsWire HAMILTON, ON and BOSTON, June...
Benzinga
3 months ago
Raymond Jameshas initiated coverage onFusion Pharmaceuticals Inc(NASDAQ: FUSN) with an Outperform rating and a Latest Ratings for FUSN DateFirmActionFromTo Aug 2021B. Riley SecuritiesInitiates Coverage OnBuy Aug 2021Morgan StanleyMaintainsOverweight May 2021Morgan StanleyMaintainsOverweight View...
CNW Group - News Releases
3 months ago
Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit Canada NewsWire HAMILTON, ON and BOSTON, June 16, 2023 HAMILTON, ON and BOSTON, June 16, 2023 /CNW/ -- Fusion...
Frequently Asked Questions
Frequently Asked Questions
What is Fusion Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Fusion Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Fusion Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Fusion Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Fusion Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Fusion Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Fusion Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Fusion Pharmaceuticals Inc?
plus_minus_icon
What percentage is Fusion Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Fusion Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.37
$-0.03
(-1.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PULMONX CORP
PULMONX CORP
$9.98
$-0.27 (-2.63 %)
Valneva SE
Valneva SE
$12.06
$-0.63 (-4.96 %)
Zomedica Corp
Zomedica Corp
$0.17
$0.00 (2.05 %)
Sundial Growers Inc
Sundial Growers Inc
$1.99
$-0.09 (-4.33 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
PULMONX CORP
PULMONX CORP
$9.98
$-0.27 (-2.63 %)
Valneva SE
Valneva SE
$12.06
$-0.63 (-4.96 %)
Zomedica Corp
Zomedica Corp
$0.17
$0.00 (2.05 %)
Sundial Growers Inc
Sundial Growers Inc
$1.99
$-0.09 (-4.33 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00